OUR PRODUCTS

MOBILE APPS

GENERAL INFO

KALV

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

KalVista Pharmaceuticals (KALV) Earnings Date & Reports

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

KALV is expected to report earnings to fall 3.17% to -95 cents per share on September 04

KalVista Pharmaceuticals KALV Stock Earnings Reports

Q3'25

Est.

$-0.96

Q2'25

Missed

by $0.14

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.03

The last earnings report on July 10 showed earnings per share of -99 cents, missing the estimate of -84 cents. With 68.93K shares outstanding, the current market capitalization sits at 675.06M.

View a ticker or compare two or three

Compare

KALV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For KALV
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KALV showed earnings on July 10, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

55 Cambridge Parkway

Phone

+1 857 999-0075

Employees

118

Web

https://www.kalvista.com